Health · Full coverage
Eli Lilly's Weight-Loss Pill 'Zepbound' to Launch in Israel
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Center 1Unrated 1
By יואב אבן, אביבית מיסניקוב, יואב אבן, אביבית מיסניקוב
First reported by Globes · 2 hours ago
What happened
Eli Lilly's oral weight-loss drug, Zepbound, will launch in Israel on September 15, making it the fourth country to offer the medication. The pill offers a convenient daily dosage and comes with a significant price range.
- 01Zepbound, an oral weight-loss drug from Eli Lilly, launches in Israel Sept. 15.
- 02Israel is the fourth country globally to approve the medication.
- 03The drug is taken daily and aids weight loss with diet and exercise.
- 04It offers a convenient alternative to weight-loss injections.
- 05Prices range from approximately 691 to 1,146 shekels.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
US Pharma Giant's Weight-Loss Pill Approved for Sale in Israel1 hour agoEli Lilly’s New Weight Loss Drug Sparks Controversy Before Market LaunchJun 30, 2026Israeli Weight-Loss Pill Developer Appoints New CEO to Revive Struggling CompanyAug 12, 2026Weight Loss Injection Reduces Appetite and Transforms Israel's Food IndustryAug 3, 2026Israeli Health Ministry Warns Against Dangerous Weight Loss Product Containing Banned DrugAug 4, 2026Next-Generation Weight-Loss Drugs Aim Beyond the ScaleJun 26, 2026